Boundless Sale Purchase Of Stock vs Capital Expenditures Analysis

BOLD Stock

USD 2.52 0.14 5.26%

Boundless Bio, financial indicator trend analysis is way more than just evaluating Boundless Bio, Common prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boundless Bio, Common is a good investment. Please check the relationship between Boundless Bio, Sale Purchase Of Stock and its Capital Expenditures accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Sale Purchase Of Stock vs Capital Expenditures

Sale Purchase Of Stock vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boundless Bio, Common Sale Purchase Of Stock account and Capital Expenditures. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Boundless Bio,'s Sale Purchase Of Stock and Capital Expenditures is 0.87. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Boundless Bio, Common, assuming nothing else is changed. The correlation between historical values of Boundless Bio,'s Sale Purchase Of Stock and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Boundless Bio, Common are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Sale Purchase Of Stock i.e., Boundless Bio,'s Sale Purchase Of Stock and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Sale Purchase Of Stock

Capital Expenditures

Capital Expenditures are funds used by Boundless Bio, Common to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Boundless Bio, operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Boundless Bio,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boundless Bio, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At present, Boundless Bio,'s Enterprise Value Multiple is projected to drop slightly based on the last few years of reporting.

	2010	2022	2023	2024 (projected)
Interest Income	96K	668K	5.3M	5.5M
Net Interest Income	96K	668K	5.3M	5.5M

Interest Income Net Interest Income

Boundless Bio, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Capital Lease Obligations
Total Assets		0.6	-0.59	0.79	0.8	0.66	0.86	-0.97	-0.9	0.97	0.99	0.49	0.94	0.99	0.06	0.65	0.97	-0.3	0.73	0.89	-0.29	0.99	0.31	0.06	0.37	-0.25
Short Long Term Debt Total	0.6		-0.26	0.83	0.57	0.69	0.9	-0.42	-0.83	0.76	0.49	0.07	0.66	0.63	0.02	0.45	0.69	-0.33	0.55	0.55	-0.31	0.63	0.76	0.02	0.43	0.24
Other Current Liab	-0.59	-0.26		-0.08	-0.12	0.12	-0.56	0.6	0.46	-0.47	-0.63	-0.22	-0.43	-0.6	0.17	-0.94	-0.56	-0.4	0.09	-0.87	-0.4	-0.59	-0.46	0.17	0.46	-0.13
Total Current Liabilities	0.79	0.83	-0.08		0.86	0.93	0.83	-0.67	-0.89	0.91	0.7	0.34	0.85	0.79	0.1	0.25	0.81	-0.61	0.91	0.52	-0.59	0.79	0.4	0.1	0.76	-0.22
Total Stockholder Equity	0.8	0.57	-0.12	0.86		0.94	0.65	-0.81	-0.68	0.82	0.79	0.74	0.94	0.75	0.5	0.14	0.72	-0.81	0.81	0.52	-0.8	0.76	0.04	0.5	0.81	-0.54
Property Plant And Equipment Net	0.66	0.69	0.12	0.93	0.94		0.64	-0.6	-0.69	0.77	0.6	0.54	0.83	0.63	0.41	-0.02	0.63	-0.86	0.87	0.33	-0.84	0.64	0.15	0.41	0.92	-0.41
Current Deferred Revenue	0.86	0.9	-0.56	0.83	0.65	0.64		-0.73	-0.96	0.93	0.78	0.22	0.83	0.88	-0.03	0.72	0.91	-0.21	0.62	0.85	-0.19	0.88	0.71	-0.03	0.3	0.09
Net Debt	-0.97	-0.42	0.6	-0.67	-0.81	-0.6	-0.73		0.76	-0.89	-0.99	-0.62	-0.92	-0.95	-0.2	-0.59	-0.9	0.34	-0.65	-0.86	0.33	-0.94	-0.11	-0.2	-0.35	0.38
Retained Earnings	-0.9	-0.83	0.46	-0.89	-0.68	-0.69	-0.96	0.76		-0.97	-0.81	-0.19	-0.83	-0.92	0.15	-0.65	-0.95	0.23	-0.77	-0.8	0.2	-0.92	-0.61	0.15	-0.39	0.01
Accounts Payable	0.97	0.76	-0.47	0.91	0.82	0.77	0.93	-0.89	-0.97		0.92	0.4	0.94	0.97	0.03	0.59	0.97	-0.38	0.81	0.82	-0.35	0.97	0.43	0.03	0.49	-0.19
Cash	0.99	0.49	-0.63	0.7	0.79	0.6	0.78	-0.99	-0.81	0.92		0.56	0.92	0.97	0.1	0.63	0.93	-0.29	0.66	0.88	-0.28	0.97	0.19	0.1	0.33	-0.32
Non Current Assets Total	0.49	0.07	-0.22	0.34	0.74	0.54	0.22	-0.62	-0.19	0.4	0.56		0.68	0.39	0.72	0.06	0.29	-0.68	0.33	0.33	-0.69	0.39	-0.21	0.72	0.51	-0.82
Non Currrent Assets Other	0.94	0.66	-0.43	0.85	0.94	0.83	0.83	-0.92	-0.83	0.94	0.92	0.68		0.91	0.34	0.47	0.88	-0.58	0.76	0.77	-0.56	0.91	0.27	0.34	0.59	-0.41
Cash And Short Term Investments	0.99	0.63	-0.6	0.79	0.75	0.63	0.88	-0.95	-0.92	0.97	0.97	0.39	0.91		0.0	0.68	0.99	-0.24	0.73	0.9	-0.22	1.0	0.35	0.0	0.33	-0.16
Good Will	0.06	0.02	0.17	0.1	0.5	0.41	-0.03	-0.2	0.15	0.03	0.1	0.72	0.34	0.0		-0.29	-0.06	-0.72	0.08	-0.03	-0.74	0.0	-0.32	1.0	0.45	-0.45
Common Stock Shares Outstanding	0.65	0.45	-0.94	0.25	0.14	-0.02	0.72	-0.59	-0.65	0.59	0.63	0.06	0.47	0.68	-0.29		0.69	0.42	0.08	0.9	0.43	0.68	0.67	-0.29	-0.39	0.25
Short Term Investments	0.97	0.69	-0.56	0.81	0.72	0.63	0.91	-0.9	-0.95	0.97	0.93	0.29	0.88	0.99	-0.06	0.69		-0.21	0.74	0.89	-0.18	0.99	0.42	-0.06	0.32	-0.07
Non Current Liabilities Total	-0.3	-0.33	-0.4	-0.61	-0.81	-0.86	-0.21	0.34	0.23	-0.38	-0.29	-0.68	-0.58	-0.24	-0.72	0.42	-0.21		-0.6	0.05	1.0	-0.25	0.23	-0.72	-0.94	0.6
Other Current Assets	0.73	0.55	0.09	0.91	0.81	0.87	0.62	-0.65	-0.77	0.81	0.66	0.33	0.76	0.73	0.08	0.08	0.74	-0.6		0.38	-0.58	0.73	0.11	0.08	0.79	-0.4
Other Stockholder Equity	0.89	0.55	-0.87	0.52	0.52	0.33	0.85	-0.86	-0.8	0.82	0.88	0.33	0.77	0.9	-0.03	0.9	0.89	0.05	0.38		0.06	0.9	0.49	-0.03	-0.04	0.03
Total Liab	-0.29	-0.31	-0.4	-0.59	-0.8	-0.84	-0.19	0.33	0.2	-0.35	-0.28	-0.69	-0.56	-0.22	-0.74	0.43	-0.18	1.0	-0.58	0.06		-0.23	0.25	-0.74	-0.93	0.61
Total Current Assets	0.99	0.63	-0.59	0.79	0.76	0.64	0.88	-0.94	-0.92	0.97	0.97	0.39	0.91	1.0	0.0	0.68	0.99	-0.25	0.73	0.9	-0.23		0.35	0.0	0.34	-0.16
Short Term Debt	0.31	0.76	-0.46	0.4	0.04	0.15	0.71	-0.11	-0.61	0.43	0.19	-0.21	0.27	0.35	-0.32	0.67	0.42	0.23	0.11	0.49	0.25	0.35		-0.32	-0.13	0.41
Intangible Assets	0.06	0.02	0.17	0.1	0.5	0.41	-0.03	-0.2	0.15	0.03	0.1	0.72	0.34	0.0	1.0	-0.29	-0.06	-0.72	0.08	-0.03	-0.74	0.0	-0.32		0.45	-0.45
Common Stock	0.37	0.43	0.46	0.76	0.81	0.92	0.3	-0.35	-0.39	0.49	0.33	0.51	0.59	0.33	0.45	-0.39	0.32	-0.94	0.79	-0.04	-0.93	0.34	-0.13	0.45		-0.55
Capital Lease Obligations	-0.25	0.24	-0.13	-0.22	-0.54	-0.41	0.09	0.38	0.01	-0.19	-0.32	-0.82	-0.41	-0.16	-0.45	0.25	-0.07	0.6	-0.4	0.03	0.61	-0.16	0.41	-0.45	-0.55

Click cells to compare fundamentals

Boundless Bio, Account Relationship Matchups

Boundless Bio, fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	178.7M	472.6M	113.7M	76.8M	129.9M	148.5M
Short Long Term Debt Total	7.2M	7.1M	377K	5.2M	2.2M	3.3M
Other Current Liab	3.7M	(2.0M)	2.4M	4.0M	4.9M	2.6M
Total Current Liabilities	17.7M	23.9M	3.9M	7.7M	9.4M	10.0M
Total Stockholder Equity	156.6M	442.8M	(38.2M)	(81.7M)	(127.1M)	(120.7M)
Property Plant And Equipment Net	24.4M	32.1M	3.1M	7.7M	4.6M	4.3M
Current Deferred Revenue	5.6M	7.7M	2.2M	3.9M	3.5M	3.6M
Net Debt	(31.8M)	(137.3M)	(33.9M)	(5.8M)	(21.5M)	(22.6M)
Retained Earnings	(190.6M)	(319.5M)	(40.8M)	(86.7M)	(136.1M)	(142.9M)
Accounts Payable	3.9M	8.1M	1.1M	1.4M	2.2M	2.5M
Cash	39.0M	144.3M	34.3M	11.0M	23.7M	38.5M
Non Current Assets Total	41.7M	52.8M	39.1M	8.8M	5.7M	5.4M
Non Currrent Assets Other	3.1M	6.4M	1.1M	533K	555K	527.3K
Cash And Short Term Investments	133.6M	414.3M	73.0M	66.7M	120.8M	121.8M
Short Term Investments	94.6M	270.0M	38.7M	55.8M	97.0M	83.3M
Liabilities And Stockholders Equity	178.7M	472.6M	113.7M	76.8M	129.9M	148.5M
Non Current Liabilities Total	6.1M	10.5M	148.0M	150.8M	247.6M	260.0M
Other Current Assets	3.4M	5.5M	1.5M	1.3M	3.5M	2.5M
Other Stockholder Equity	47.3M	462.3M	2.8M	5.4M	9.0M	8.5M
Total Liab	22.1M	29.8M	151.9M	158.5M	257.0M	269.8M
Total Current Assets	137.0M	419.8M	74.6M	68.0M	124.2M	124.3M
Accumulated Other Comprehensive Income	(80K)	(60K)	(175K)	(398K)	40K	42K
Short Term Debt	4.6M	2.3M	377K	2.3M	2.2M	2.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Boundless Bio, Common is a strong investment it is important to analyze Boundless Bio,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio,'s future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports:

How To Invest In Boundless

Details

Is Boundless Stock a good investment?

Details

What is Boundless Bio,'s Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.59)

Return On Assets

(0.24)

Return On Equity

(0.36)

The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boundless Sale Purchase Of Stock vs Capital Expenditures Analysis

Sale Purchase Of Stock vs Capital Expenditures

Sale Purchase Of Stock vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Sale Purchase Of Stock

Capital Expenditures

Boundless Bio, fundamental ratios Correlations

Boundless Bio, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boundless Bio, fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Intangible Assets	+ 1.0	Good Will
Total Liab	+ 1.0	Non Current Liabilities Total
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Accounts Payable	- 0.97	Retained Earnings
Net Debt	- 0.97	Total Assets
Retained Earnings	- 0.96	Current Deferred Revenue
Short Term Investments	- 0.95	Retained Earnings
Cash And Short Term Investments	- 0.95	Net Debt